Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | September 24, 2009 | ||||
| Last Updated Date | September 24, 2009 | ||||
| Start Date ICMJE | January 2009 | ||||
| Primary Completion Date | April 2009 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
Diabetes summary quality measure [ Time Frame: 4 months ] [ Designated as safety issue: No ] | ||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | No Changes Posted | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care? | ||||
| Official Title ICMJE | Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?" | ||||
| Brief Summary | The purpose of this study is to determine if tailored letters sent to diabetic patients will improve care of diabetes. |
||||
| Detailed Description | Diabetes care in the US is less than optimal. Some authors have found that targeted patient letters are also an effective tool to improve outcomes when they are part of a comprehensive disease management plan. Local patient satisfaction surveys had revealed that many patients had sub‐optimal understanding of diabetes measures and of the importance of controlling these measures to reduce diabetic complications. We wondered if tailored patient letters and enclosed lab orders when due might increase patient awareness of diabetes measures and increase patient engagement.We hypothesized that the addition of targeted patient letters with enclosed lab orders to an ongoing performance improvement program would further improve diabetes care. We conducted a randomized controlled study of tailored patient letters and diabetes lab orders at our two resident‐based clinics. |
||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Not Provided | ||||
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Health Services Research |
||||
| Condition ICMJE | Diabetes Mellitus | ||||
| Intervention ICMJE | Other: Tailored letter | ||||
| Study Arm (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 467 | ||||
| Completion Date | July 2009 | ||||
| Primary Completion Date | April 2009 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years to 75 Years | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | United States | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00984841 | ||||
| Other Study ID Numbers ICMJE | STRP001 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | John R Guzek, MD, Scranton-Temple Residency Program | ||||
| Study Sponsor ICMJE | Scranton-Temple Residency Program | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Scranton-Temple Residency Program | ||||
| Verification Date | September 2009 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||